Ensign Peak Advisors
XRAY icon

Ensign Peak Advisors’s Dentsply Sirona XRAY Stock Holding History

Ensign Peak Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Buy
13,939
+200
+1% +$2.18K ﹤0.01% 1503
2026
Q1 		$159K Hold
13,739
– – ﹤0.01% 1418
2025
Q4 		$157K Sell
13,739
-36,200
-72% -$425K ﹤0.01% 1420
2025
Q3 		$634K Sell
49,939
-16,100
-24% -$234K ﹤0.01% 1274
2025
Q2 		$1.05M Hold
66,039
– – ﹤0.01% 1222
2025
Q1 		$987K Hold
66,039
– – ﹤0.01% 1251
2024
Q4 		$1.25M Sell
66,039
-40,565
-38% -$858K ﹤0.01% 1175
2024
Q3 		$2.88M Buy
106,604
+40,565
+61% +$1.04M 0.01% 803
2024
Q2 		$1.65M Hold
66,039
– – ﹤0.01% 1004
2024
Q1 		$2.19M Sell
66,039
-12,831
-16% -$438K ﹤0.01% 890
2023
Q4 		$2.81M Buy
78,870
+3,649
+5% +$116K 0.01% 786
2023
Q3 		$2.57M Hold
75,221
– – 0.01% 758
2023
Q2 		$3.01M Buy
75,221
+750
+1% +$29.8K 0.01% 739
2023
Q1 		$2.93M Buy
74,471
+5,550
+8% +$204K 0.01% 705
2022
Q4 		$2.19M Buy
68,921
+13,340
+24% +$402K ﹤0.01% 778
2022
Q3 		$1.58M Buy
55,581
+2,230
+4% +$76.2K ﹤0.01% 864
2022
Q2 		$1.91M Sell
53,351
-186
-0.3% -$7.52K ﹤0.01% 822
2022
Q1 		$2.63M Sell
53,537
-31,596
-37% -$1.67M 0.01% 783
2021
Q4 		$4.75M Buy
85,133
+39,449
+86% +$2.17M 0.01% 679
2021
Q3 		$2.65M Buy
45,684
+9,934
+28% +$612K 0.01% 952
2021
Q2 		$2.26M Buy
35,750
+2,240
+7% +$148K ﹤0.01% 1058
2021
Q1 		$2.14M Buy
33,510
+10
+0% +$580 ﹤0.01% 1080
2020
Q4 		$1.75M Sell
33,500
-93,585
-74% -$4.62M ﹤0.01% 1138
2020
Q3 		$5.56M Sell
127,085
-112,399
-47% -$4.97M 0.01% 592
2020
Q2 		$10.6M Buy
239,484
+95,495
+66% +$4.04M 0.03% 415
2020
Q1 		$5.59M Buy
143,989
+91,203
+173% +$4.65M 0.02% 482
2019
Q4 		$2.99M Buy
+52,786
New +$2.94M 0.01% 853

Other funds holding XRAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Ensign Peak Advisors's XRAY Position: Q2 2026 in Review

Ensign Peak Advisors increased its Dentsply Sirona (XRAY) stake by 1.5% in Q2 2026, buying an estimated $2.18K and bringing the position to 13,939 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #1503.

Ensign Peak Advisors first reported a position in XRAY in Q4 2019 and has held it in 27 quarters since. The position peaked at $10.6M in Q2 2020. 374 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Ensign Peak Advisors held 13,939 shares of Dentsply Sirona worth $148K as of Q2 2026.
  • Ensign Peak Advisors bought 200 Dentsply Sirona shares in Q2 2026, an estimated $2.18K.
  • Dentsply Sirona made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #1503 holding.
  • Ensign Peak Advisors first reported a position in Dentsply Sirona in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Dentsply Sirona position peaked at $10.6M in Q2 2020.
  • 374 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.